Literature DB >> 3027380

Expression of polyomavirus virion proteins by a vaccinia virus vector: association of VP1 and VP2 with the nuclear framework.

N M Stamatos, S Chakrabarti, B Moss, J D Hare.   

Abstract

The polyomavirus proteins VP1, VP2, and VP3 move from their cytoplasmic site of synthesis into the nucleus, where virus assembly occurs. To identify cellular or viral components which might control this process, we determined the distribution of VP1, VP2, and VP3 in a soluble fraction, a cytoplasmic cytoskeleton fraction, and a nuclear framework fraction of infected cells. All three proteins were detected in a detergent-extractable form immediately after their synthesis in polyomavirus-infected cells. Approximately 50, 25, and 40% of pulse-labeled VP1, VP2, and VP3, respectively, associated with the skeletal framework of the nucleus within 10 min after their synthesis. The remaining portion of each labeled protein failed to accumulate on the nuclear framework during a 40-min chase and was degraded. When expressed separately by recombinant vaccinia viruses, VP1 and VP2, but not VP3, accumulated on the nuclear framework. This association was not dependent on other polyomavirus proteins or viral DNA. The amount of total VP1 and VP2 which was bound to the nuclear framework approximated 45 and 20%, respectively. Indirect immunofluorescence demonstrated an exclusive nuclear localization of VP1 in situ. In coinfection experiments, a greater percentage of total VP2 and VP3 was bound to the nuclear framework of cells which cosynthesized VP1. These results indicate that although VP1 and VP2 can bind independently to the insoluble nuclear framework, the association of VP3 with this nuclear structure is promoted by the presence of VP1.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3027380      PMCID: PMC253976          DOI: 10.1128/JVI.61.2.516-525.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  The purification fo four strains of poxvirus.

Authors:  W K JOKLIK
Journal:  Virology       Date:  1962-09       Impact factor: 3.616

2.  Construction of improved M13 vectors using oligodeoxynucleotide-directed mutagenesis.

Authors:  J Norrander; T Kempe; J Messing
Journal:  Gene       Date:  1983-12       Impact factor: 3.688

3.  Herpes simplex virus and protein transport are associated with the cytoskeletal framework and the nuclear matrix in infected BSC-1 cells.

Authors:  A Ben-Ze'ev; R Abulafia; S Bratosin
Journal:  Virology       Date:  1983-09       Impact factor: 3.616

4.  Nuclear localization of herpesvirus proteins: potential role for the cellular framework.

Authors:  M P Quinlan; D M Knipe
Journal:  Mol Cell Biol       Date:  1983-03       Impact factor: 4.272

5.  Subcellular distribution of viral structural proteins during simian virus 40 infection.

Authors:  W Lin; T Hata; H Kasamatsu
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

6.  General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.

Authors:  M Mackett; G L Smith; B Moss
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

7.  Targeting of E. coli beta-galactosidase to the nucleus in yeast.

Authors:  M N Hall; L Hereford; I Herskowitz
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

8.  Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters.

Authors:  G L Smith; B R Murphy; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

9.  SV40 virions and viral RNA metabolism are associated with cellular substructures.

Authors:  A Ben-Ze'ev; R Abulafia; Y Aloni
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

10.  Functional histone antibody fragments traverse the nuclear envelope.

Authors:  L Einck; M Bustin
Journal:  J Cell Biol       Date:  1984-01       Impact factor: 10.539

View more
  16 in total

1.  Recombinant vaccinia viruses. Design, generation, and isolation.

Authors:  C C Broder; P L Earl
Journal:  Mol Biotechnol       Date:  1999-12-15       Impact factor: 2.695

2.  Identification of amino acid residues within simian virus 40 capsid proteins Vp1, Vp2, and Vp3 that are required for their interaction and for viral infection.

Authors:  Akira Nakanishi; Akiko Nakamura; Robert Liddington; Harumi Kasamatsu
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

3.  Nuclear localization of Semliki Forest virus-specific nonstructural protein nsP2.

Authors:  J Peränen; M Rikkonen; P Liljeström; L Kääriäinen
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

4.  Myristylated polyomavirus VP2: role in the life cycle of the virus.

Authors:  N Krauzewicz; C H Streuli; N Stuart-Smith; M D Jones; S Wallace; B E Griffin
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

5.  Expression of the polyomavirus minor capsid proteins VP2 and VP3 in Escherichia coli: in vitro interactions with recombinant VP1 capsomeres.

Authors:  S E Delos; T P Cripe; A D Leavitt; H Greisman; R L Garcea
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

6.  Cooperation of structural proteins during late events in the life cycle of polyomavirus.

Authors:  J Forstová; N Krauzewicz; S Wallace; A J Street; S M Dilworth; S Beard; B E Griffin
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

7.  Functional complementation of nuclear targeting-defective mutants of simian virus 40 structural proteins.

Authors:  N Ishii; A Nakanishi; M Yamada; M H Macalalad; H Kasamatsu
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  Mutations in the VP1 coding region of polyomavirus determine differentiating stage specificity.

Authors:  L Ricci; R Maione; C Passananti; A Felsani; P Amati
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

9.  Assembly of viruslike particles by recombinant structural proteins of adeno-associated virus type 2 in insect cells.

Authors:  M Ruffing; H Zentgraf; J A Kleinschmidt
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

10.  Cutting edge: shift in antigen dependence by an antiviral MHC class Ib-restricted CD8 T cell response during persistent viral infection.

Authors:  Phillip A Swanson; Amelia R Hofstetter; Jarad J Wilson; Aron E Lukacher
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.